Correlate Infrastructure Partners (OTCQB: CIPI), a technology-enabled energy optimization and clean energy solutions provider for all of North America, has published a new interview with its Vice President of Sales Jim Fiorentino. During the interview, Fiorentino discussed his introduction to the clean tech space and Correlate, as well as the team’s focus to implement advanced…
Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(R), today announced key highlights from the completed feasibility study conducted by its partner HI, LLC dba Kernel (“Kernel”). The study was designed to evaluate Kernel’s Flow(R) wearable technology to measure ketamine’s psychedelic effect on cerebral cortex hemodynamics. “The results from…
FingerMotion (NASDAQ: FNGR), a mobile services and data company, has announced its financial results for the third quarter ended Nov. 30, 2022. Among the highlights, the company reported record quarterly revenue of $11.40 million and a quarterly increase in revenues of 93% compared to Q3 2022. “The Chinese ‘lockdowns’ are over now, but during the…
Data443 Risk Mitigation (OTC: ATDS), a data security and privacy software company for “All Things Data Security,” is releasing an update regarding its proposed uplist to the Nasdaq Capital Market. According to the announcement, based on the company’s annual report filing on Form 10-K for FY 2022, ATDS will no longer be subject to NASDAQ’s…
Jupiter Wellness (NASDAQ: JUPW), a company focused on hair, skin and sexual wellness, last week became the second NASDAQ company to dual list on Upstream under the ticker symbol JUPW. Jupiter Wellness released a digital collectible NFT to commemorate the dual listing, which is available for all Upstream participants to claim with the code “JUPW.”…
Lexaria Bioscience (NASDAQ: LEXX) CEO Chris Bunka has released an annual letter to shareholders. The detailed letter talks about company highlights throughout the year, including the fact that, despite challenges such as global supply chain disruptions and threatening inflation, “Lexaria continues to navigate well and is focused on those things it can control such as…
BiondVax (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, recently announced statistically significant (p<0.001) efficacy results in a preclinical in-vivo proof-of-concept study of its innovative inhaled nanosized antibody (“NanoAb”) COVID-19 therapy. “The study concluded that compared to pre-infection weight, the…
Eloro Resources’ (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) EVP of Exploration Bill Pearson was recently part of an interview on Business TV (“BTV”) where he expressed his optimism on the company’s prospects following its recent exploratory work at its Iska Iska project located in southern Bolivia. “[Pearson also simultaneously suggested] that the possibility that Eloro…
Jupiter Wellness (NASDAQ: JUPW), a company focused on hair, skin and sexual wellness, is in an ideal position to be “profitable” in 2023. That was the outlook reported in a shareholder letter released by JUPW CEO Brian John. The letter noted 2022 highlights, such as the company becoming the second U.S. equity to dual list…
Cerberus Sentinel (NASDAQ: CISO) founder and CEO David Jemmett was featured on a recent episode of Gamechangers LIVE(R) with host Sergio Tigera. The podcast series shines a spotlight on individuals who are gamechangers in their fields and shares perspectives on their journeys, mindsets, struggles and successes in an effort to inspire and inform listeners. In…
Lexaria Bioscience Corp. (NASDAQ: LEXX) in 2022 achieved crucial milestones centered around its patented DehydraTECH(TM) drug delivery technology. “For Lexaria, the end goal does not only lie in uncovering DehydraTECH’s ability to improve the bioavailability of various APIs. Instead, the company is keen on establishing whether DehydraTECH can be applied broadly within the pharmaceutical industry.…
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced an investigator-initiated phase 1b /2 trial evaluating the company’s novel anthracycline, Berubicin. The study, titled “Evaluation of the safety and efficacy of Berubicin in the treatment of…
Vision Energy (OTC: VENG) (the “Company”) today issued statements regarding recent removal from the OTCQB Market. On Dec. 6, 2022, Vision Energy was informed by the OTC Markets Group Inc. of certain promotional material that encouraged investors to purchase or trade the Company’s common stock. On Jan. 10, 2022, the Company was informed that, due…
Golden Matrix Group (NASDAQ: GMGI) is a developer, licensor and global operator of online gaming and eCommerce platforms, systems and gaming content. The company today announced its entry into a definitive acquisition agreement pursuant to which it has agreed to acquire MeridianBet Group and its related companies in a cash and stock transaction valued at…
HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, anywhere, was featured in a new C-level interview with Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap publicly traded companies. Branislav Vajdic, PhD, CEO…
Cybin (NYSE American: CYBN) (NEO: CYBN) is a biotechnology company focused on progressing Psychedelics to Therapeutics(R). The company today announced that it has selected Generalized Anxiety Disorder (“GAD”) with or without major depressive disorder (“MDD”) as the target indication for CYB004 — its proprietary deuterated N, N-dimethyltryptamine (“DMT”) molecule. “Based on preclinical data, CYB004 has…
Aditxt (NASDAQ: ADTX), a biotech innovation company, is developing and commercializing technologies with a focus on monitoring and modulating, mapping and reprogramming the immune system, designing technologies to provide a personalized immune profile. “In late October 2022, Aditxt announced the creation of its Adimune(TM) program. At the same time, Aditxt announced that Adimune initiated the…
Correlate Infrastructure Partners (OTCQB: CIPI), a tech-enabled distributed energy solutions company, works as a platform for helping businesses in the commercial real estate industry acquire solutions for solar, cogeneration, energy storage, and electric vehicle infrastructure to improve their environmental, social and governance (“ESG”) position. “In working with global stored energy solutions leader EnerSys(R) (NYSE: ENS)…
CISO Global (NASDAQ: CISO), an industry leader as a managed cybersecurity and compliance provider formally known as Cerberus Sentinel, has signed a definitive agreement to acquire RAN Security, a cybersecurity company headquartered in Buenos Aires, Argentina, and with offices in Chile, Peru, Bolivia, and Paraguay. According to the agreement, RAN Security will become a wholly…